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INTRODUCTION
Myiasis, or the infestation of living vertebrates with
dipterous (two-winged fly) larvae, can take many forms.
Depending on their species, maggots will feed on living
or dead tissue, liquid body substances, or even ingested
food.1 The anatomical classification system of such larvae
is based on the host location of infestation: sanguinivorous, cavitary, or cutaneous, including furuncular,
migratory, or wound.1 While pathologic myiasis can result
in significant morbidity in both humans and livestock,
therapeutic myiasis has played an important role in
wound debridement for centuries. This article will explore
the varying forms of pathologic cutaneous myiasis and
the evolving role of therapeutic myiasis by presenting the
case of a patient admitted with newly identified infestation
of bilateral lower extremity wounds.

Figure 1. Superficial lower extremity wounds without purulence, edema, erythema,
or other evidence of superimposed bacterial infection.

Table 1: Diptera larval species responsible for varying forms
of cutaneous myiasis.
Cutaneous Myiasis

Diptera Larval Species

Furuncle Myiasis

Dermatobia
Cordylobia
Cuterebra s
Wohlfahrtia
W opaca

Migratory Myiasis

Gasterophilus
Hypoderma spp.

Wound Myiasis

Facultative
Lucilia seriata
Obligatory
Cochliomyia
Chrysomya
W magnifica

hominis
anthropophagia
pp.
vigil
intestinalis
parasites
parasites
hominivorax
bezziana

consulted for potential debridement. However, it was
noted on inspection that his extremities were devoid of
any necrotic tissue to debride. The lack of necrotic tissue
was attributed to the maggot infestation. Topical betadine
solution was applied and two doses of ivermectin 400
mcg/kg/dose were administered to treat concomitant
body lice. Three days after initiation of these therapies,
the wounds began to exude purulent and malodorous
drainage with evidence of newly developed necrotic
tissue. Local wound care with daily dressing changes
incorporating Santyl (collagenase), Medihoney, and
betadine-soaked gauze were continued for the remainder
of the hospital course to prevent further infection.

CASE PRESENTATION

DISCUSSION

The patient is a 59-year-old homeless man with a history
of poorly-controlled schizophrenia who presented to the
Thomas Jefferson University Hospital (TJUH) Emergency
Department with bilateral leg pain. On examination, his
legs had multiple areas of superficial ulceration with pale
larvae (Figure 1). There was no purulent drainage to
suggest superimposed bacterial infection, and his vital
signs and laboratory studies demonstrated no signs of
systemic illness. The patient was admitted for management
of necrotic wounds complicated by myiasis. Surgery was

Pathologic myiasis is most frequently seen in tropical
and travel medicine settings, though maggots can be
easily found all over the world, including the United
States.2 Cutaneous myiasis—furuncular, migratory, or
wound—is the fourth most reported skin disease in
returning travelers.3 Poor hygiene and low socioeconomic
status, which were noted in our patient, serve as risk
factors for pathologic myiasis even in developed
countries. 4 Wounds most susceptible to pathologic
myiasis include neuropathic ulcers, vascular insufficiency
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ulcers, psoriasis, hemorrhoids, impetigo, and malignant
wounds. 4 Given its prevalence, an understanding of
identifying and treating various forms of cutaneous
myiasis and superimposed bacterial infections such as
tetanus is important.
Furuncular myiasis develops following larval penetration
into the healthy exposed skin of travelers or inhabitants of
tropical regions, with an incubation period of one to two
days. A pruritic, painful, and erythematous nodule forms,
with a central dimple facilitating larval respiration and
releasing serosanguinous or purulent fluid—and through
which a single or multiple larvae can be directly observed.5
Agitation and insomnia can occur even in localized
myiasis, while systemic symptoms of fevers, chills, and
lymphadenopathy suggest secondary bacterial infection.
While larvae responsible for furuncular myiasis tend to
stay localized within the primary nodule, those of
migratory myiasis burrow through the skin and lead to the
development of pruritic lesions with raised red borders.4
These erythematous lesions that are the result of initial
larval infestation fade to yellow patches once the larva
migrates to a new site. In so doing, larvae can live for
months in human skin, rarely penetrating visceral organs
and brain and lung parenchyma. Migratory myiasis is
typically associated with animal exposures, as the Diptera
species involved cannot complete their larval life cycles in
human hosts and instead relies on cattle and horses as
intermediate hosts.
Wound myiasis, such as was seen in our patient, results
when flies occupy and lay eggs in open wounds, especially
those with necrotic, hemorrhaging, or purulent lesions.4
Facultative parasites feed only on dead tissue within a
wound, excrete antimicrobial and alkaline substances to
inhibit bacterial growth, and stimulate granulation—
providing utility in wound debridement for centuries.6
Obligatory parasites, on the other hand, require living
tissue for larval development, and are thus prone to cause
local destruction, fistula formation, as well as invasion of
deep tissue requiring immediate removal.5 Examination of
the wound itself can help determine whether the larvae are
facultative or obligatory. Facultative parasites often remain
superficial and visible to the naked eye, consuming necrotic
tissue on a microscopic level to leave behind clean margins
and healthy granulation tissue. Obligatory parasites
produce foul-smelling discharge, localized swelling, and
deep pockets of infection. Therapeutic myiasis involves the
careful selection and sterile harvesting of facultative
species, such as Lucilia sericata, which will effectively serve
to debride, disinfect, and enhance healing at the wound
site (Table 1). Clinical indications for the use of therapeutic
myiasis include wounds infected with multi-drug resistant
bacteria, superficial wounds, non-healing ulcers and burns,
and the presence of significant medical comorbidities
precluding surgical debridement. Exudate, wound odor,
and pain sores have all been demonstrated to decrease
with therapeutic myiasis when compared to conventional
dressings.6 All studies to date have used laboratory-bred
sterile maggots; no studies to our knowledge have
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evaluated outcomes in patients presenting with wounds
already infested with maggots.
Diagnosis of pathologic myiasis is usually clinical, although
dermoscopy and ultrasound have been employed in the
detection of larvae within furuncular lesions and along
migratory tracts.4 Peripheral eosinophilia and elevated IgE
levels may be observed in patients with chronic or recurrent
myiasis, though these values may be normal in the context
of acute infestation. Once identified, pathologic larvae
should be killed using one of three techniques: application
of a toxic substance to the larvae; production of localized
hypoxia (i.e. via occlusion of the central dimple with
petroleum or paraffin) to force the larvae to emerge from
the furuncle; or mechanical/surgical removal of the larvae.4
Regardless of the mechanism of killing employed, dead
larvae should be removed to prevent secondary bacterial
infection. Systemic therapy is not recommended for
furuncular myiasis in the absence of secondary bacterial
infection, as dead larvae may remain trapped within the
nodule, resulting in a subsequent inflammatory reaction
and development of a nidus.4 Eradication of obligatory
parasites in wound myiasis is similarly performed on a local
level, involving application of antiseptic solution or topical
ivermectin to the wound. In addition, oral ivermectin or
albendazole have been reported to bring migratory larvae
closer to the skin surface facilitating subsequent extraction.

KEY POINTS
Therapeutic myiasis has long been employed in controlled
settings for the management of chronic, poorly-healing
wounds. Enzymes found in the gastrointestinal tracts of
some species confer antimicrobial properties to this
localized therapy. However, it should be stated that not all
maggots are created equal. Obligate larvae feed on all
tissues thereby endangering human hosts, while facultative
larvae feed preferentially on necrotic tissues—making
them ideal therapeutic agents. Despite being used with
great regularity for local wound care in ancient cultures,
the mere thought of maggots has made many physicians
shudder since the advent of germ theory in the second
half of the 19th century.6 While it has yet to be definitively
proven in any scientific studies, preserving and identifying
maggots that prefer necrotic over living tissue could help
debride extensive wounds and allow for timely healing.

REFERENCES
1. Sherman RA. Wound Myiasis in Urban and Suburban United States. Archives of
Internal Medicine 2000;160:2004-2014.
2. Solomon M, Lachish T, Schwartz E. Cutaneous Myiasis. Tropical, Travel, and
Emerging Infections 2016;18:28.
3. Robbins K, Khachemoune A. Cutaneous Myiasis: A Review of the Common Types
of Myiasis. International Journal of Dermatology 2010;49:1092-1098.
4. Francesconi F, Lupi O. Myiasis. Clinical Microbiology Reviews 2012;25:79-105.
5. McGraw TA, Turiansky GW. Cutaneous Myiasis. Journal of the American Academy
of Dermatology 2008;58:907-926.
6. Whitaker IS, Twine C, Whitaker MJ, et. al. Larval Therapy from Antiquity to the
Present Day: Mechanisms of Action, Clinical Applications, and Future Potential.
Postgraduate Medical Journal 2007;83:409-413.

